FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma

Clinical trial NCT07314372 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07314372
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Unresectable Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC)Liver Cancer Adult

Start date: 2026-02-01
Primary completion: 2027-12-31
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.